Xencor Appoints Bart Cornelissen As Senior Vice President and Chief Financial Officer
04/09/24, 12:02 PM
Location
pasadenaIndustry
biopharma
therapeutics
biotechnology
health care
Position
chief financial officer
vice president
Xencor, Inc. announced the appointment of Bart Cornelissen to senior vice president and chief financial officer. Mr
Company Info
Location
pasadena, california, united states
Additional Info
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.
Related People
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Bh
Bh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more